The main cause of blood cancer is acquired genetic mutations — changes in the DNA of blood-forming cells in your bone marrow that cause them to grow uncontrollably. These mutations aren’t typically inherited. In roughly 90% of cases, they develop spontaneously during your lifetime through a combination of environmental exposures, aging errors in DNA replication, and sometimes plain biological bad luck. There is no single “smoking gun” the way cigarettes cause lung cancer, which is exactly why blood cancers feel so unpredictable to patients and families.
That said, we do know specific triggers that dramatically increase the risk of these mutations. Chronic benzene exposure, prior chemotherapy or radiation, certain viral infections, and inherited genetic syndromes all have strong, well-documented links. Let’s break down what the science actually shows — and what you can realistically do about it.
How Blood Cancer Develops at the Cellular Level
Blood cancers — which include leukemia, lymphoma, and multiple myeloma — all start the same way. A blood-forming stem cell in the bone marrow or a mature blood cell in the lymphatic system acquires a mutation that gives it a survival or growth advantage over normal cells. That single rogue cell divides, crowds out healthy blood cells, and eventually causes symptoms.
The specific mutation determines which type of blood cancer develops. For example, the Philadelphia chromosome (a translocation between chromosomes 9 and 22) drives about 95% of chronic myeloid leukemia (CML) cases. Mutations in the MYD88 gene appear in over 90% of Waldenström macroglobulinemia cases. These aren’t inherited defects — they’re acquired hits to DNA that accumulate over time.
Globally, blood cancers account for approximately 6.5% of all new cancer diagnoses. The American Cancer Society estimates over 186,000 new cases of blood cancer in the U.S. annually, with leukemia, lymphoma, and myeloma each contributing significantly.
Known Risk Factors Ranked by Evidence Strength
Not all risk factors carry the same weight. Here’s how the evidence stacks up:
| Risk Factor | Associated Blood Cancers | Relative Risk Increase | Evidence Level |
|---|---|---|---|
| Prior chemotherapy/radiation | AML, MDS | 5–10x | Strong |
| Chronic benzene exposure | AML, ALL, MDS | 2–7x | Strong |
| Epstein-Barr virus (EBV) | Burkitt lymphoma, Hodgkin lymphoma | 3–5x | Strong |
| Family history (first-degree relative) | CLL, Hodgkin lymphoma | 2–4x | Moderate |
| Age over 60 | Most types, especially AML and myeloma | Significantly elevated | Strong |
| Down syndrome | ALL, AML | 10–20x | Strong |
| HTLV-1 virus | Adult T-cell leukemia/lymphoma | 2–5% lifetime risk in carriers | Strong |
| Smoking | AML | 1.2–1.6x | Moderate |
| Obesity | Multiple myeloma, some lymphomas | 1.2–1.5x | Moderate |
Environmental and Chemical Exposures
Benzene remains the most clearly established chemical cause of blood cancer in humans. Workers in petroleum refining, rubber manufacturing, and shoe production historically faced the highest exposures. The EPA classifies benzene as a Group A carcinogen, and even low-level chronic exposure (above 1 ppm over years) increases leukemia risk measurably.
Pesticides, herbicides (particularly Agent Orange), and formaldehyde have also been linked to non-Hodgkin lymphoma and leukemia in occupational studies, though the evidence is less definitive than for benzene.
Prior Cancer Treatment
Therapy-related blood cancers are a cruel irony. Patients who survive one cancer with alkylating agents (like cyclophosphamide) or topoisomerase II inhibitors have a 5–10% cumulative risk of developing therapy-related AML or MDS within 5–10 years. Radiation therapy, particularly to large body fields, adds further risk.
Viral Infections
Epstein-Barr virus is found in tumor cells of nearly all endemic Burkitt lymphoma cases in sub-Saharan Africa and about 40% of Hodgkin lymphoma cases worldwide. HTLV-1, endemic in parts of Japan, the Caribbean, and Central Africa, directly causes adult T-cell leukemia/lymphoma. Hepatitis C is associated with certain B-cell lymphomas through chronic immune stimulation.
Genetics and Family History
True inherited blood cancer syndromes are rare — accounting for roughly 5–10% of cases. However, having a first-degree relative with chronic lymphocytic leukemia (CLL) increases your risk by about 6–9 times. Conditions like Li-Fraumeni syndrome, Fanconi anemia, and ataxia-telangiectasia carry substantially elevated blood cancer risk.
Warning Signs You Shouldn’t Ignore
Blood cancer symptoms are notoriously vague, which delays diagnosis by an average of several weeks to months. Watch for these red flags:
- Persistent fatigue that doesn’t improve with rest
- Unexplained fevers or recurrent infections
- Easy bruising or bleeding that seems disproportionate to the injury
- Unintentional weight loss exceeding 10% of body weight in 6 months
- Painless swollen lymph nodes in the neck, armpit, or groin lasting more than 2 weeks
- Drenching night sweats (the kind that soak through your sheets)
- Bone pain, especially in the back or ribs (common in myeloma)
How Blood Cancer Is Diagnosed
Diagnosis typically begins with a complete blood count (CBC). A markedly elevated white blood cell count, unexplained anemia, or low platelet count triggers further workup. A peripheral blood smear examined under the microscope can reveal abnormal cells — blast cells in leukemia, for example.
Definitive diagnosis usually requires a bone marrow biopsy, which allows pathologists to assess cell morphology, perform flow cytometry, and run cytogenetic testing to identify specific mutations. Imaging with CT or PET scans is standard for lymphoma staging.
When to See a Doctor
See your doctor promptly if you have:
- Any combination of the warning signs listed above lasting more than 2 weeks
- A known history of benzene or radiation exposure
- A first-degree relative diagnosed with blood cancer before age 55
- A prior cancer treated with chemotherapy or radiation
Ask specifically for a CBC with differential and peripheral smear. If results are abnormal, request a referral to a hematologist-oncologist — don’t wait for a repeat test in 3 months.
Frequently Asked Questions
Is blood cancer hereditary?
Most blood cancers are not hereditary. Only about 5–10% have a clear inherited genetic component. Having a family member with blood cancer modestly raises your risk for certain types (especially CLL), but the vast majority of cases arise from mutations acquired during a person’s lifetime.
Can blood cancer be prevented?
There’s no guaranteed way to prevent blood cancer, but you can lower your risk by avoiding benzene exposure, not smoking, maintaining a healthy weight, and following safety protocols if you work with industrial chemicals. If you’ve had prior chemotherapy, your oncologist should monitor your blood counts regularly.
What is the most common blood cancer?
Non-Hodgkin lymphoma is the most common blood cancer overall, accounting for roughly 80,000+ new U.S. cases annually. Leukemia follows at approximately 60,000 new cases per year, with multiple myeloma adding about 35,000 cases.
Does stress cause blood cancer?
There is no direct evidence that psychological stress causes blood cancer. While chronic stress affects immune function and overall health, no clinical study has established a causal link between stress and hematologic malignancy. Focus on modifiable risk factors with proven associations instead.
At what age is blood cancer most commonly diagnosed?
It depends on the type. Acute lymphoblastic leukemia (ALL) peaks in children ages 2–5, while most other blood cancers — AML, CLL, myeloma, and many lymphomas — are diagnosed predominantly in adults over 60. The median age at diagnosis for multiple myeloma is 69.
